期刊文献+

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma 被引量:4

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma
下载PDF
导出
摘要 The purpose of this study was to determine the relationship between hypermethylation of DACT1 gene pro-moter and lower mRNA expression in bladder urothelial carcinoma tissue.The methylation status of 29 urothelial carcinoma samples and 29 normal tissue samples were examined by methylation-specific polymerase chain reac-tion(MSP).The DACT1 mRNA transcript levels and DACT1 protein levels in all samples were then evaluated to define the relationship between the methylation status of the DACT1 promoter and its expression at the transcrip-tional and translational levels.Decreased expression of DACT1 was detected in 89.66% of urothelial carcinomas(26/29;P 〈 0.005).Promoter hypermethylation was found in 58.62%(17/29) urothelial carcinomas and 25%(7/29) normal tissues,respectively(P 〈 0.05).DACT1 expression was lower in tissues where the DACT1 gene promoter was hypermethylated than in unmethylated tissues(0.25±0.17 vs 0.69±0.30,P 〈 0.05).DACT1 gene hyper-methylation was closely related to tumor size,grade and stage(P 〈 0.05).Our results indicate that silencing and downregulation of DACT1 mRNA may be implicated in carcinogenesis and the progression of bladder urothelial carcinoma,and may be a potential prognostic factor. The purpose of this study was to determine the relationship between hypermethylation of DACT1 gene pro-moter and lower mRNA expression in bladder urothelial carcinoma tissue.The methylation status of 29 urothelial carcinoma samples and 29 normal tissue samples were examined by methylation-specific polymerase chain reac-tion(MSP).The DACT1 mRNA transcript levels and DACT1 protein levels in all samples were then evaluated to define the relationship between the methylation status of the DACT1 promoter and its expression at the transcrip-tional and translational levels.Decreased expression of DACT1 was detected in 89.66% of urothelial carcinomas(26/29;P 〈 0.005).Promoter hypermethylation was found in 58.62%(17/29) urothelial carcinomas and 25%(7/29) normal tissues,respectively(P 〈 0.05).DACT1 expression was lower in tissues where the DACT1 gene promoter was hypermethylated than in unmethylated tissues(0.25±0.17 vs 0.69±0.30,P 〈 0.05).DACT1 gene hyper-methylation was closely related to tumor size,grade and stage(P 〈 0.05).Our results indicate that silencing and downregulation of DACT1 mRNA may be implicated in carcinogenesis and the progression of bladder urothelial carcinoma,and may be a potential prognostic factor.
机构地区 Department of Urology
出处 《The Journal of Biomedical Research》 CAS 2012年第5期319-324,共6页 生物医学研究杂志(英文版)
关键词 DNA methylation DACT1 HYPERMETHYLATION bladder urothelial carcinoma DNA methylation, DACT1, hypermethylation, bladder urothelial carcinoma
  • 相关文献

参考文献1

二级参考文献9

  • 1Okamura S, Ng C, Koyama K, et al. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system.Oncol Res ,1999, 11:281-285.
  • 2Carter W, Hoying J, Boswell C, et al.HER2/neu over-expression induces endothelial cell retraction. Int J Cancer ,2001,91:295-299.
  • 3Mahabeleshwar GH, Kundu GC. SYK, a protein tyrosine kinase suppresses the cell motility and nuclear factor kB mediated secretion of urokinase type plas minogen activator by inhibiting the phosphatidylinositol 3′-kinase activity in breast cancer cells. J
  • 4Zhang YL, Fu ZR, Zhang J, et al. Inhibition of invasiveness of human mammary carcinoma cell line MDA435 by heparanase antisense oligodeoxynucleotide. Natl Med J China, 2003,83:204-206.张友磊,傅志仁,张军,等.乙酰肝素酶反义
  • 5Kiyonao S, Tomoko T, Shigeru Y,et al. Structure and function of syk protein-tyrosine kinase. J Biochem ,2001, 130, 177-186.
  • 6Toyama T, Iwase H, Yamashita H,et al. Reduced expression of the syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett, 2003,189:97-102.
  • 7Yuan R, Mendez A, Sahin J. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res,2001, 61 : 5558-5561.
  • 8Stewart Z, Pietenpol J. syk: a new player in the field of breast cancer. Breast Cancer Res, 2001,3:5-7.
  • 9Coopman J, Do M, Barth M, et al. The syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature,2000,406 :742-747.

共引文献18

同被引文献3

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部